Ian Michael Ball

Ian Michael Ball

Auto-generated profile, based on publicly available information

Ian Michael Ball

Division of Critical Care, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
ATAlexis F. Turgeon
Alexis F. Turgeon
DFDean A. Fergusson
Dean A. Fergusson
LCLucy Clayton
Lucy Clayton
MPMarie-Pier Patton
Marie-Pier Patton
XNXavier Neveu
Xavier Neveu
FLFrançois Lauzier
François Lauzier
The effect of a liberal transfusion strategy as compared with a restrictive strategy on outcomes in critically ill patients with traumatic brain injury is unclear. We randomly assigned adults with moderate or severe traumatic brain injury and anemia to receive transfusion of red cells according to a liberal strategy (transfusions initiated at a hemoglobin level of ≤10 g per deciliter) or a restrictive strategy (transfusions initiated at ≤7 g per deciliter). The primary outcome was an unfavorable outcome as assessed by the score on the Glasgow Outcome Scale-Extended at 6 months, which we categorized with the use of a sliding dichotomy that was based on the prognosis of each patient at baseline. Secondary outcomes included mortality, functional independence, quality of life, and depression at 6 months. A total of 742 patients underwent randomization, with 371 assigned to each group. The analysis of the primary outcome included 722 patients. The median hemoglobin level in the intensive care unit was 10.8 g per deciliter in the group assigned to the liberal strategy and 8.8 g per deciliter in the group assigned to the restrictive strategy. An unfavorable outcome occurred in 249 of 364 patients (68.4%) in the liberal-strategy group and in 263 of 358 (73.5%) in the restrictive-strategy group (adjusted absolute difference, restrictive strategy vs. liberal strategy, 5.4 percentage points; 95% confidence interval, -2.9 to 13.7). Among survivors, a liberal strategy was associated with higher scores on some but not all the scales assessing functional independence and quality of life. No association was observed between the transfusion strategy and mortality or depression. Venous thromboembolic events occurred in 8.4% of the patients in each group, and acute respiratory distress syndrome occurred in 3.3% and 0.8% of patients in the liberal-strategy and restrictive-strategy groups, respectively. In critically ill patients with traumatic brain injury and anemia, a liberal transfusion strategy did not reduce the risk of an unfavorable neurologic outcome at 6 months. (Funded by the Canadian Institutes of Health Research and others; HEMOTION ClinicalTrials.gov number, NCT03260478.).

4 July 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
DCDeborah Cook
Deborah Cook
ADAdam Deane
Adam Deane
FLFrançois Lauzier
François Lauzier
NZNicole Zytaruk
Nicole Zytaruk
GGGordon Guyatt
Gordon Guyatt
SFSimon Finfer
Simon Finfer
Whether proton-pump inhibitors are beneficial or harmful for stress ulcer prophylaxis in critically ill patients undergoing invasive ventilation is unclear. In this international, randomized trial, we assigned critically ill adults who were undergoing invasive ventilation to receive intravenous pantoprazole (at a dose of 40 mg daily) or matching placebo. The primary efficacy outcome was clinically important upper gastrointestinal bleeding in the intensive care unit (ICU) at 90 days, and the primary safety outcome was death from any cause at 90 days. Multiplicity-adjusted key secondary outcomes were ventilator-associated pneumonia, Clostridioides difficile infection, and patient-important bleeding. A total of 4821 patients underwent randomization in 68 ICUs. Clinically important upper gastrointestinal bleeding occurred in 25 of 2385 patients (1.0%) receiving pantoprazole and in 84 of 2377 patients (3.5%) receiving placebo (hazard ratio, 0.30; 95% confidence interval [CI], 0.19 to 0.47; P<0.001). At 90 days, death was reported in 696 of 2390 patients (29.1%) in the pantoprazole group and in 734 of 2379 patients (30.9%) in the placebo group (hazard ratio, 0.94; 95% CI, 0.85 to 1.04; P = 0.25). Patient-important bleeding was reduced with pantoprazole; all other key secondary outcomes were similar in the two groups. Among patients undergoing invasive ventilation, pantoprazole resulted in a significantly lower risk of clinically important upper gastrointestinal bleeding than placebo, with no significant effect on mortality. (Funded by the Canadian Institutes of Health Research and others; REVISE ClinicalTrials.gov number, NCT03374800.).

5 April 2020 in Canadian Medical Association Journal
Verified
Journal Article
Closed access
PDF file
IBIan M. Ball
Ian M. Ball
LHLaura Hornby
Laura Hornby
BRBram Rochwerg
Bram Rochwerg
MWMatthew J. Weiss
Matthew J. Weiss
CGClay Gillrie
Clay Gillrie
SSSam D. Shemie
Sam D. Shemie

27 December 2016 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
IBIan M. Ball
Ian M. Ball
SBSean M. Bagshaw
Sean M. Bagshaw
KBKaren E. A. Burns
Karen E. A. Burns
DCDeborah J. Cook
Deborah J. Cook
ADAndrew G. Day
Andrew G. Day
ISIan G. Stiell
Ian G. Stiell

6 February 2020 in New England Journal of Medicine
Verified
Journal Article
Open access
IBIan M. Ball
Ian M. Ball
AHAndrew Healey
Andrew Healey
SKSean Keenan
Sean Keenan
FPFran Priestap
Fran Priestap
JBJohn Basmaji
John Basmaji
MWMatthew Weiss
Matthew Weiss
Medical assistance in dying followed by organ donation is new to North America. If chosen, this path offers potential donors the opportunity to fulfill their last requests and may also affect transplant waiting lists. This letter discusses organ donation after euthanasia and its implications.

1 October 2016 in Journal of Critical Care
Verified
Journal Article
Closed access
IBIan M. Ball
Ian M. Ball
SBSean M. Bagshaw
Sean M. Bagshaw
KBKaren E.A. Burns
Karen E.A. Burns
DCDeborah J. Cook
Deborah J. Cook
ADAndrew G. Day
Andrew G. Day
ISIan G. Stiell
Ian G. Stiell